Literature DB >> 32516304

Postconditioning with Nitrates Protects Against Myocardial Reperfusion Injury: A New Use for an Old Pharmacological Agent.

Zhu Meng1, Weili Gai1, Dalin Song1.   

Abstract

Early reperfusion remains the key therapy to salvage viable myocardium and must be applied as soon as possible following an acute myocardial infarction (AMI) to attenuate the ischemic insult. However, reperfusion injury may develop following reintroduction of blood and oxygen to vulnerable myocytes, which results in more severe cell death than in the preceding ischemic episode. Ischemic postconditioning (I-PostC) provides a cardioprotective effect in combination with pharmacological agents. Although nitrates have been tested in many experimental and clinical studies of acute AMI to evaluate the cardioprotective effect, few investigations have been focused on nitrates postconditioning in patients undergoing percutaneous coronary intervention (PCI). This review presents the manifestations of myocardial reperfusion injury (RI) and potential mechanisms underlying it, and provides the mechanisms involved in the cardioprotection of I-PostC. We also present a new therapeutic approach to attenuate RI by use of an 'old' agent - nitrates - in AMI patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32516304      PMCID: PMC7299064          DOI: 10.12659/MSM.923129

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  93 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Evaluation of the effects of ischemic preconditioning with a short reperfusion phase on patients undergoing a coronary artery bypass graft.

Authors:  Mohammad Jebeli; Hamid Reza Esmaili; Mohammad Hussein Mandegar; Mohammad R Rasouli; Payam Eghtesadi-Araghi; Robabeh Mohammadzadeh; Ali Darehzereshki; Saied Dianat
Journal:  Ann Thorac Cardiovasc Surg       Date:  2010-08       Impact factor: 1.520

3.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy.

Authors:  D Hackett; G Davies; S Chierchia; A Maseri
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

4.  Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.

Authors:  Laurent Argaud; Odile Gateau-Roesch; Danina Muntean; Lara Chalabreysse; Joseph Loufouat; Dominique Robert; Michel Ovize
Journal:  J Mol Cell Cardiol       Date:  2005-01-26       Impact factor: 5.000

5.  Prompt improvement of left ventricular function and preservation of topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction.

Authors:  B I Jugdutt; B L Schwarz-Michorowski; W J Tymchak; J R Burton
Journal:  Cardiology       Date:  1997 Mar-Apr       Impact factor: 1.869

6.  Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.

Authors:  Shu-Fang Pi; Ying-Wu Liu; Tong Li; Yu Wang; Quan Zhou; Bo-Jiang Liu; Wen-Jin Peng; Xin Li; Yun-Yun Wang; Lei Huang
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

7.  Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.

Authors:  Ke Wei; Vahid Serpooshan; Cecilia Hurtado; Marta Diez-Cuñado; Mingming Zhao; Sonomi Maruyama; Wenhong Zhu; Giovanni Fajardo; Michela Noseda; Kazuto Nakamura; Xueying Tian; Qiaozhen Liu; Andrew Wang; Yuka Matsuura; Paul Bushway; Wenqing Cai; Alex Savchenko; Morteza Mahmoudi; Michael D Schneider; Maurice J B van den Hoff; Manish J Butte; Phillip C Yang; Kenneth Walsh; Bin Zhou; Daniel Bernstein; Mark Mercola; Pilar Ruiz-Lozano
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

8.  Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.

Authors:  Liam M McCormick; Stephen P Hoole; Paul A White; Philip A Read; Richard G Axell; Sophie J Clarke; Michael O'Sullivan; Nick E J West; David P Dutka
Journal:  JACC Cardiovasc Interv       Date:  2015-02       Impact factor: 11.195

9.  Cardioprotective Effect of Isosorbide Dinitrate Postconditioning Against Rat Myocardial Ischemia-Reperfusion Injury In Vivo.

Authors:  Xinwen Zhao; Mengjuan Wang; Mei Li; Na Wu; Dalin Song
Journal:  Med Sci Monit       Date:  2019-03-02

10.  Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo.

Authors:  Xujun Wang; Marco Bruno Morelli; Alessandro Matarese; Celestino Sardu; Gaetano Santulli
Journal:  ESC Heart Fail       Date:  2020-01-25
View more
  1 in total

1.  Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction.

Authors:  Branka Mitić; Andriana Jovanović; Valentina N Nikolić; Dragana Stokanović; Olivera M Andrejić; Rada M Vučić; Milan Pavlović; Aleksandra Ignjatović; Stefan Momčilović
Journal:  Medicina (Kaunas)       Date:  2022-02-14       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.